Clinical Trial Update: Steroid Treatment for Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating steroid treatment for kidney diseases (nephrotic syndrome and focal segmental glomerulosclerosis), with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis
• Nephrotic Syndrome

Drugs mentioned

• PREDNISONE (Prednisone)
• Prednisolone (Prednisolone)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Nephrosis, Focal Lipoid Glomerulosclerosis | Phase 3 | Status: COMPLETED | Results posted: 2011-10-28